Chemoinformaics analysis of Calarane
Molecular Weight | 206.373 | nRot | 0 |
Heavy Atom Molecular Weight | 180.165 | nRig | 13 |
Exact Molecular Weight | 206.203 | nRing | 3 |
Solubility: LogS | -5.92 | nHRing | 0 |
Solubility: LogP | 4.874 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 3 |
No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 3 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 42.3866 |
nHD | 0 | BPOL | 26.0834 |
QED | 0.547 |
Synth | 4.13 |
Natural Product Likeliness | 2.548 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.345 |
Pgp-sub | 0 |
HIA | 0.003 |
CACO-2 | -4.663 |
MDCK | 0.0000155 |
BBB | 0.859 |
PPB | 0.941912 |
VDSS | 2.031 |
FU | 0.0501376 |
CYP1A2-inh | 0.269 |
CYP1A2-sub | 0.685 |
CYP2c19-inh | 0.292 |
CYP2c19-sub | 0.922 |
CYP2c9-inh | 0.353 |
CYP2c9-sub | 0.731 |
CYP2d6-inh | 0.03 |
CYP2d6-sub | 0.795 |
CYP3a4-inh | 0.167 |
CYP3a4-sub | 0.349 |
CL | 16.784 |
T12 | 0.041 |
hERG | 0.009 |
Ames | 0.003 |
ROA | 0.119 |
SkinSen | 0.262 |
Carcinogencity | 0.011 |
EI | 0.24 |
Respiratory | 0.948 |
NR-Aromatase | 0.015 |
Antiviral | Yes |
Prediction | 0.917931 |